US 8227247B2
· Zhang et al.
· 2012
[cited by applicant]
US 8633025B2
· Vanderhaeghen et al.
· 2014
[cited by applicant]
US 20200087622A1
· Nair et al.
· 2020
[cited by applicant]
US 20210047618A1
· Clevers et al.
· 2021
[cited by applicant]
US 20220177835A1
· Studer et al.
· 2022
[cited by applicant]
US 20230027059A1
· Amini
· 2023
[cited by applicant]
US 20230332103A1
· Amini et al.
· 2023
[cited by applicant]
US 20240117303A1
· Amini
· 2024
[cited by applicant]
US 20240158743A1
· Amini
· 2024
[cited by applicant]
US 20240158744A1
· Amini
· 2024
[cited by applicant]
CN 110042082A
· 2019
[cited by applicant]
EP 3031908A1
· 2016
[cited by applicant]
WO 2012162124A1
· 2012
[cited by applicant]
WO 2013163228A1
· 2013
[cited by applicant]
WO 2016103269A1
· 2016
[cited by applicant]
WO 2016162747A2
· 2016
[cited by applicant]
WO 2018208836A1
· 2018
[cited by applicant]
WO 2020219696A1
· 2020
[cited by applicant]
WO 2021119209A1
· 2021
[cited by applicant]
WO 2021224496A1
· 2021
[cited by applicant]
WO 2023003621A1
· 2023
[cited by applicant]
WO 2023010897A1
· 2023
[cited by applicant]
WO 2023075913A1
· 2023
[cited by applicant]
García-León, et al. SOX10 Single transcription factor-based fast and efficient generation of oligodendrocytes from human pluripotent stem cells. Stem Cell Reports. 2018; 10(1):655-672. (Year: 2018).
[cited by examiner]
Algarni, A. et al. “Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth,” European Journal of Pharmacology, vol. 820:113-129. (20…
[cited by applicant]
Med Chem Express (Akt). 8 pages https://www.medchemexpress.com/Targets/Akt.html?effectName=Activator&page=3 (2024).
[cited by applicant]
Tang, F. et al., “Resveratrol Enhances Neurite Outgrowth and Synaptogenesis Via Sonic Hedgehog Signaling Following Oxygen-Glucose Deprivation/Reoxygenation Injury,” Cell Phys Biochem., vol. 43:852-869 (2017).
[cited by applicant]
Arenas, E. et al., “How to make a midbrain dopaminergic neuron,” Development, vol. 142(11):1918-1936 (2015).
[cited by applicant]
Brodski C. et al., “Crosstalk of Intercellular Signaling Pathways in the Generation of Midbrain Dopaminergic Neurons In Vivo and from Stem Cells,” Journal of Developmental Biology, vol. 7(1):p. 3 (2019).
[cited by applicant]
Bukys, M. et al., “High-Dimensional Design-Of-Experiments Extracts Small-Molecule-Only Induction Conditions for Dorsal Pancreatic Endoderm from Pluripotency,” Iscience, vol. 23(8):101346: 35 pages (2020).
[cited by applicant]
Cooper, O. et al., “Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid,” Mo…
[cited by applicant]
Douvaras & Fossati, “Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells,” Nature Protocols, vol. 10(8):1143-1154 (2015).
[cited by applicant]
Douvaras, P. et al., “Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells,” Stem Cell Reports, vol. 3(2):250-259 (2014).
[cited by applicant]
Drummond, N. et al., “Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation,” Front. Cell. Dev. Biol., vol. 8:578907 (2020).
[cited by applicant]
Fedele, S. et al., “Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential,” Sci. Reports, vol. 7:6036 (2017).
[cited by applicant]
Ferri, A. et al., “Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner,” Development, vol. 134:2761-2769 (2007).
[cited by applicant]
Garcia Leon, J-A.et al., “Generation of oligodendrocytes and establishment of an all-human myelinating platform from human pluripotent stem cells,” Nature Protocols, vol. 15 (11):3716-3744 (2020).
[cited by applicant]
Garcia-Leon, J. et al., “SOX10 Single Transcription Factor-Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells,” Stem Cell Reports, vol. 10(2):655-672 (2018).
[cited by applicant]
Gantner, C. et al., “An Optimized Protocol for the Generation of Midbrain Dopamine Neurons under Defined Conditions,” Star Protocols, vol. 1(2):100065 (2020).
[cited by applicant]
Hartfield et al., “Physiological characterisation of human iPS-derived dopaminergic neurons,” PLoS One, vol. 92: e87388 (2014).
[cited by applicant]
Hu, B-Y. et al., “Differentiation of human oligodendrocytes from pluripotent stem cells,” Nature Protocols, vol. 4 (11):1614-1622 (2009).
[cited by applicant]
International Preliminary Report on Patentability, PCT/US2022/014306, dated Oct. 3, 2023, 10 pages.
[cited by applicant]
International Search Report and Written Opinion, PCT/US2022/014306, dated May 16, 2022, 18 pages.
[cited by applicant]
International Search Report and Written Opinion, PCT/US2022/029979, dated Jan. 4, 2023, 17 pages.
[cited by applicant]
International Search Report and Written Opinion, PCT/US2022/041663, dated Dec. 13, 2022, 23 pages.
[cited by applicant]
International Search Report and Written Opinion, PCT/US2023/022819, dated Oct. 23, 2023, 13 pages.
[cited by applicant]
Kim, S. et al., Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment, Progress in Neurobiology, …
[cited by applicant]
Kriks, S. et al., “Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.” Nature, vol. 480(7378):547-51 (2011).
[cited by applicant]
Kriks, S. et al., “Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD,” Nature, vol. 480(7387):547-551 (2011).
[cited by applicant]
Liu, Y et al.,“Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells,” Nature Protocols, vol. 8(9):1670-1679 (2013).
[cited by applicant]
Livesey, M et al., “Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes,” Stem Cells 34(4):1040-1053 (2016).
[cited by applicant]
Maroof, A. et al., “Directed Differentiation and Functional Maturation of Cortical Interneurons from Human Embryonic Stem Cells,” Cell Stem Cell, vol. 12(5):559-572 (2013).
[cited by applicant]
Namchaiw, P. et al., “Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro,” Stem Cell Res & Therapy, vol. 10(1):272 (2019).
[cited by applicant]
Nicholas, C. et al., “Functional Maturation of hPSC-Derived Forebrain Interneurons Requires an Extended Timeline and Mimics Human Neural Development,” Cell Stem Cell, vol. 12(5):573-586 (2013).
[cited by applicant]
Nolbrant, S. et al., “Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation,” Nature Protocols, vol. 12(9):1962-1979 (2017).
[cited by applicant]
Piao, J. et al., “Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation,” Cell Stem Cell 16(2):198-210 (2015).
[cited by applicant]
Playne R. et al., “Understanding Parkinson's Disease through the Use of Cell Reprogramming,” Stem Cells Reviews and Reports, vol. 13(2):151-169 (2017).
[cited by applicant]
Precious, S. et al., “Dopaminergic Progenitors Derived From Epiblast Stem Cells Function Similarly to Primary VM-Derived Progenitors When Transplanted Into a Parkinson's Disease Model,” Front. Neurosci., vol. 14:312 (20…
[cited by applicant]
Qu Q. et al., “High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1,” NAture Communications, vol. 5 (1): (2014).
[cited by applicant]
Riemens, R. et al., “Directing neuronal cell fatein vitro: Achievements and challenges,” Progress in Neurobiology, vol. 168: 42-68 (2018).
[cited by applicant]
Thomson, J.A. et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282(5391):1145-1147 (1998).
[cited by applicant]
Tyler W. A. et al., “Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation,” The Journal of Neuroscience, vol. 29(19):6367-6378 (2009).
[cited by applicant]
Urbanek, P et al., Cooperation of Pax2 and Pax5 in midbrain and cerebellum development, Proc. Natl. Acad. Sci., vol. 94(11):5703-5708 (1997).
[cited by applicant]
Vernay, B. et al. “Otx2 regulates subtype specification and neurogenesis in the midbrain,” J. Neurosci., vol. 25 (19):4856-4867 (2005).
[cited by applicant]
Walaa F. Alsanie et al., “Human Embryonic Stem Cell-Derived Oligodendrocytes: Protocols and Perspectives,” Stem Cells and Development, vol. 22(18):2459-2476 (2013).
[cited by applicant]
Wang, M. et al., “Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside ,” Cells, vol. 9:1489 (2020).
[cited by applicant]
Wang, S. et al., “Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination,” Cell Stem Cell, vol. 12(2):252-264 (2013).
[cited by applicant]
Yamashita, T. et al., “Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells,” PLOS One, vol. 12(2): e0171947: 16 pages (2017).
[cited by applicant]
Yan, C. et al., “Lmx1a and Imx1b function cooperatively to regulate proliferation, specification, and differentiation of midbrain dopaminergic progenitors,” J. Neurosci., vol. 31(35):12413-12425 (2011).
[cited by applicant]
Yang, H. et al., “Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes,” Stem Cell Res. Therap., vol. 10(1):195 (2019).
[cited by applicant]
Yu, J. et al. “Human induced pluripotent stem cells free of vector and transgene sequences,” Science 324 (5928):797-801 (2009).
[cited by applicant]
Feigenson, K. et al., “Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation,” ASN Neuro, vol. 3 (3)(art:e00061):147-158 (2011) doi:10.1042/AN20110004.
[cited by applicant]
Goldman, S.A. et al., “How to make an oligodendrocyte,”Development, vol. 142(23):3983-3995 (2015).
[cited by applicant]
Guardiola-Diaz, H. et al., “Erk1/2 MAPK and mTOR Signaling Sequentially Regulates Progression Through Distinct Stages Of Oligodendrocyte Differentiation,” Glia., vol. 60(3): 476-486 (2012) doi:10.1002/glia.22281.
[cited by applicant]
International Preliminary Report on Patentability, PCT/US2022/029979, dated Jan. 18, 2024, 7 pages.
[cited by applicant]
International Search Report and Written Opinion, PCT/US2023/024792, dated May 22, 2024, 11 pages.
[cited by applicant]
Mccaughey-Chapman, A. et al., “Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies,” Journal of Neuroscience Research, vol. 10…
[cited by applicant]
Kalani, M. Yashar et al, “Wnt-mediated self-renewal of neural stem/progenitor cells,” PNAS, vol. 105(44):16970-16975 (2008).
[cited by applicant]
Adams, K. et al. “Intrinsic and extrinsic regulators of oligodendrocyte progenitor proliferation and differentiation,” Seminars in Cell and Developmental Biology, vol. 116: 16-24 (2021).
[cited by applicant]
Alvarez-Dolado, M. et al., “Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain,” J. Neurosci., vol. 26(28):7380-7389 (2006).
[cited by applicant]
Baraban, S et al., “Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice,” Proc. Natl. Acad. Sci., vol. 106(36):15472-15477 (2009).
[cited by applicant]
Batista-Brito, R. et al., “The cell-intrinsic requirement of Sox6 for cortical interneuron development,” Neuron, vol. 63:466-481 (2009).
[cited by applicant]
Comella-Bolla, A. et al., “Human Pluripotent Stem Cell-Derived Neurons Are Functionally Mature In Vitro and Integrate into the Mouse Striatum Following Transplantation,” Mol. Neurobiol. vol. 57(6):2766-2798 (2020).
[cited by applicant]
Crompton, L. et al., “Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling,” Stem Cell Res., vol. 11:1206-1221 (2013).
[cited by applicant]
De Angelis, M. et al., “Short-term retinoic acid treatment sustains pluripotency and suppresses differentiation of human induced pluripotent stem cells,” Cell Death and Disease, vol. 9(1):1-13. (2018).
[cited by applicant]
Fishell and Rudy, “Mechanisms of inhibition within the telencephalon: “where the wild things are,”” Annu. Rev. Neurosci., vol. 34:535:567 (2011).
[cited by applicant]
Guo, C. et al., “Fezf2 expression identifies a multipotent progenitor for neocortical projection neurons, astrocytes, and oligodendrocytes,” Neuron, vol. 80(5):1167-1174. (2013).
[cited by applicant]
Gusel'Nikova et al., “NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker,” Acta Naturae, vol. 7:42-47 (2015).
[cited by applicant]
Hansen et al., “Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences,” Nature Neurosci., vol. 16(11):1576-1587 (2013).
[cited by applicant]
Hoch, R. et al., “OTX2 Transcription Factor Controls Regional Patterning within the Medial Ganglionic Eminence (MGE) and Regional Identity of the Septum,” Cell Reports, vol. 12(3):482-494 (2015).
[cited by applicant]
Horn and Nicoll, “Somatostatin and parvalbumin inhibitory synapses onto hippocampal pyramidal neurons are regulated by distinct mechanisms,” Proc. Natl. Acad. Sci., vol. 115(3):589-594 (2018).
[cited by applicant]
Huebner, L. et al., “FEZF2's Role in Differentiation and Proliferation in Radial Glial Cells During Cortical Development,” University of California, Santa Cruz Dissertations Publishing, pp. 1-33 (2020).
[cited by applicant]
Ihnatovych, I. et al., “Timing of Wnt Inhibition Modulates Directed Differentiation of Medial Ganglionic Eminence Progenitors from Human Pluripotent Stem Cells,” Stem Cells International, vol. 2018, Article ID 3983090, …
[cited by applicant]
Jang, Y. et al., “Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells,” Journal of Neuroscience Research, vol. 75(4): 573-584 (2004).
[cited by applicant]
Kioussi, C. et al., “Pax6 is essential for establishing ventral-dorsal cell boundaries in pituitary gland development,” Proc. Natl. Acad. Sci., vol. 96(25):14378-14382 (1999).
[cited by applicant]
Lagutin et al., “Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development,” Genes & Development, vol. 17(3):368-379 (2003).
[cited by applicant]
Le Magueresse and Monyer, “GABAergic interneurons shape the functional maturation of the cortex,” Neuron 77(3):388-405 (2013).
[cited by applicant]
Leoni, G. et al., “NG2 cells differentiate into astrocytes in cerebellar slices,” Molecular and Cellular Neuroscience, vol. 42(3): 208-218 (2009).
[cited by applicant]
Liu, Y. et al., “Oligodendrocyte and Astrocyte Development in Rodents: An In Situ and Immunohistological Analysis During Embryonic Development,” Glia, vol. 40(1): 25-43 (2002).
[cited by applicant]
Lybrand, Z. et al., “Stem cells: A path towards improved epilepsy therapies,” Neuropharm., vol. 168:107781 (2020).
[cited by applicant]
Marques, S et al., “Transcriptional Convergence of Oligodendrocyte Lineage Progenitors during Development,” Developmental Cell, vol. 46(4): 504-517 (2018).
[cited by applicant]
Mayer, C. et al., “Developmental diversification of cortical inhibitory interneurons,” Nature, 555(7697):457-462 (2018).
[cited by applicant]
Nahar, L. et al., “The Role of Parvalbumin Interneurons in Neurotransmitter Balance and Neurological Disease,” Front. Psych., vol. 12:679960 (2021).
[cited by applicant]
Nguyen, R. et al., “Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia,” J. Neurosci., vol. 34(45):14948-14960 (2014).
[cited by applicant]
Pai, E. et al., “Maf and Mafb control mouse pallial interneuron fate and maturation through neuropsychiatric disease gene regulation,” Elife, vol. 9:54903 (2020).
[cited by applicant]
Shetty and Upadhya, “GABA-ergic cell therapy for epilepsy: Advances, limitations and challenges,” Neurosci. Biobehav. Rev., vol. 62:35-47 (2016).
[cited by applicant]
Shi, Z. et al., “Conversion of Fibroblasts to Parvalbumin Neurons by One Transcription Factor, Ascl1, and the Chemical Compound Forskolin,” J. Biol. Chem., vol. 291(26):13560-13570 (2016).
[cited by applicant]
Silberberg, S. et al., “Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate,” Neuron, vol. 92(1):59-74 (2016).
[cited by applicant]
Stoykova, A. et al., “Pax6 modulates the dorsoventral patterning of the mammalian telencephalon,” J. Neurosci. 20(21):8042-8050 (2000).
[cited by applicant]
Trotter, J. et al., “NG2 cells: Properties, progeny and origin,” Brain Research Reviews, vol. 63(1-2): 72-82 (2010).
[cited by applicant]
Wang, Y et al., “DIx5 and DIx6 regulate the development of parvalbumin-expressing cortical interneurons,” J. Neurosci., vol. 30(15):5334-5345 (2010).
[cited by applicant]
Wen, W et al., “Mesencephalic Astrocyte-Derived Neurotrophic Factor (MAN F) Regulates Neurite Outgrowth Through the Activation of Akt/mTOR,” Front. Mol. Neurosci., vol. 13:1-17 (2020).
[cited by applicant]
Yan, Y. et al., “Efficient and rapid derivation of primitive neural stem cells and generation of brain subtype neurons from human pluripotent stem cells,” Stem Cells Transl. Med., vol. 2(11): 862-870 (2013).
[cited by applicant]
Yuan, F. et al., “Efficient generation of region-specific forebrain neurons from human pluripotent stem cells under highly defined condition,” Sci Rep., vol. 5:18550 (2015).
[cited by applicant]
Yuan, F. et al., “Induction of human somatostatin and parvalbumin neurons by expressing a single transcription factor LIM homeobox 6,” Elife, vol. 7:e37382 (2018).
[cited by applicant]
Zhang et al., “Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons,” Cell Stem Cell, vol. 17: 735-747 (2015).
[cited by applicant]
Zhang et al., “Supplemental Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons,” Cell Stem Cell, vol. 17: 48 pages. (2015).
[cited by applicant]
Zhang, S. et al., “Fezf2 promotes neuronal differentiation through localised activation of Wnt/ß-catenin signalling during forebrain development,” Development, vol. 141(24):4794-47805 (2014).
[cited by applicant]
Zhou, J et al., “A Revolution in Reprogramming: Small Molecules,” Current Molecular Medicine, vol. 19(2): 77-90 (2019).
[cited by applicant]
International Preliminary Report on Patentability, PCT/US2022/041663, dated Apr. 30, 2024, 14 pages.
[cited by applicant]